Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRED
NCT04381143Phase 4Active, not recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jul 2020
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Aspirin with Matching Placebo (2 arms). Primary endpoint: Major Cardiovascular Events at 5 years. Started Jul 2020; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04381143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381143.